Oriola has completed the sale of its Baltic businesses

Oriola Corporation press release October 19, 2017 at 09:00 AM

Oriola has completed the sale of its Baltic businesses

Oriola has completed the sale of its Baltic businesses. On 14 August 2017 Oriola announced that it had signed an agreement to sell its Baltic businesses to the companies’ existing management (SIA Oribalt Group). Oriola’s Baltic businesses comprise of the following subsidiaries: AS Oriola, Oriola Estonia Oü, SIA Oriola Riga, SIA Panpharmacy, and UAB Oriola Vilnius. The net sales of the Baltic businesses in 2016 were EUR 54 million, the adjusted EBIT EUR 1.2 million and the number of personnel 160. Oriola will focus on developing its businesses in the Nordic countries.

Further information:

Tuula Lehto
Communications Director, Oriola Corporation
+358 40 588 5343
tuula.Lehto@oriola.com

Publisher:
Oriola Corporation
Group Communications
Orionintie 5
02200 Espoo, Finland
www.oriola.com

Oriola

Oriola is a Finnish listed retail and wholesale company that distributes pharmaceuticals and health and wellbeing products. Oriola has a strong position in the pharmaceuticals market in Sweden and Finland. We promote people’s wellbeing by ensuring safe and efficient distribution of pharmaceuticals and healthcare consumer products and services to our customers. Oriola’s net sales are EUR 1.6 billion, the company has some 2,800 employees and 325 pharmacies in Sweden. The company is headquartered in Espoo. www.oriola.com